The Peter Moss Acute Myeloid & Lymphoblastic AI Research Project is a collection of projects focusing on the use of artificial intelligence and other modern technologies in the battle against Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL).

The research project was founded in 2018 when Peter Moss was diagnosed with AML and given a few weeks to live. The research project was founded by Peter's eldest grandson, Adam Milton-Barker later joined by co-founders Prof. Ho Leung Ng and Dr Amita Kapoor. This research project was the foundations for what became Asociación de Investigacion en Inteligencia Artificial Para la Leucemia Peter Moss.

The immediate challenge for Peter's family was finding information and advice that could help them understand how to live with and understand the disease. The concept of a platform dedicated to sharing open information about Leukemia began to shape and the AML & ALL Research Archives Github repository was launched in February 2019, this archive evolved and is now a core feature of our Association, Asociación de Investigacion en Inteligencia Artificial Para la Leucemia Peter Moss Information Database.

AML has no known warning signs, so early detection is very hard if not impossible. In Peter's case, the disease was completely missed in a standard blood test 1 month before being diagnosed with AML. Adam was convinced that there must have been signs in that blood test, and possibly in earlier results, he set out to form a team of volunteers with the goals of using Artificial Intelligence for the early detection of Acute Myeloid Leukemia.

The lack of open datasets for Acute Myeloid Leukemia at the time proved to be a hard hurdle to overcome. In October 2018, Adam reached out on Artificial Intelligence and Deep Learning Facebook Group enquiring about open Leukemia datasets suitable for training a classifier. Professor Ho Leung Ng Assoc. Professor Biochemistry & Molecular Biophysics at Kansas State University and Leukemia survivor responded to assist Adam, and not long after joined the research project to focus on using Artificial Intelligence for drug discovery.

Ho introduced Adam to the Acute Lymphoblastic Leukemia Image Database for Image Processing dataset by Fabio Scotti - Associate Professor Dipartimento di Informatica @ Università degli Studi di Milano. This dataset became the foundation of our leukemia research and development for around two years.

Adam had worked with Dr Amita Kapoor Associate Professor at Delhi University in a number of personal projects in the past and Amita joined Adam and Ho to co-found the research project. During her time as a volunteer to the research project Amita mostly worked on early detection of Acute Lymphoblastic Leukemia and assisted in the running of the first Student Program.

Whilst visiting his family in Florida Adam had the opportunity to speak with one of the doctors assisting Peter at Hematology Oncology Associates of The Treasure Coast, Port St Lucie, Dr Jones. Adam discussed the idea for the project with Dr Jones and received some invaluable advice and support, convincing Adam that the idea was worth persuing.

During the next two years the research project continued to grow and evolve. The team had the opportunity to demonstrate/present our projects at several events in Europe with Intel including Embedded World 2019, Nuremberg, Germany, Intel Dev Affinity Day 2019, Munich, Germany and Codemotion 2019, Madrid, Spain, and our first development project was voted 1st in Europe out of 4 projects, and awarded the Intel® DevMesh AI Spotlight Award which was a new designation granted by Intel recognizing inspiring and breakthrough Artificial Intelligence projects in development from the Intel software community.

Estela Cabezas joined the team as a student in 2019 to gain experience of working with Artificial Intelligence for medical use cases. Estela was able to use our project as case study in her thesis: Applied Analytics for clinical decision support and presented our project at Embedded World 2019, Intel Dev Affinity Day 2019 and Codemotion Madrid 2019. We launched a student program where we planned to provide students opportunities to work on open-source technologies that could be used in the fight against Leukemia, and to provide students opportunities to demonstrate and talk about our projects at events and conferences.

In 2019 Peter Moss sadly passed away following a year long battle with Acute Myeloid Leukemia. After getting permission from his family, Adam, Ho, Amita and the rest of the team started to prepare to launch a non-profit organization to continue the research projects in memory of Peter.

In 2021, Peter Moss Acute Myeloid & Lymphoblastic AI Research Project remains an important research project and our volunteers have open-sourced over 10 projects that focus on the early detection of Acute Lymphoblastic Leukemia.